Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Opinion Volume 5 Issue 5

Molecules and Clonality in Cancer

Daniel Gandia*

IQVIA, Hematology and Oncology Strategy Unit, Buenos Aires, Argentina

*Corresponding Author: Daniel Gandia, IQVIA, Hematology and Oncology Strategy Unit, Buenos Aires, Argentina.

Received: March 31, 2021; Published: April 10, 2020

Cancer is without doubt, one of the most important Internal Medicine diseases.

  The advances in the clinical setting treatment of this disease are huge, with the advantage, that many Basic Science disciplines, such as Molecular Biology, Biochemistry and Pharmacology positively impact in the understanding of this process.

  We discover permanently new basic Cancer cell issues, such as modifications of normal biochemical pathways that the cell uses for its metabolism and growth, but when Cancer is present, the alterations are many and may not be all countable yet.

References

Citation

Citation: Daniel Gandia. “Molecules and Clonality in Cancer". Acta Scientific Medical Sciences 5.5 (2021): 19-20.

Copyright

Copyright: © 2021 Daniel Gandia. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US